Form 4: Credo CFO Sells $15.5M in Shares Under 10b5-1 Plan
Insider Transaction Report
Credo Technology Group's CFO, Daniel W. Fleming, sold 112,580 ordinary shares for approximately $15.56 million on October 8, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.
Summary
- Daniel W. Fleming, Chief Financial Officer of Credo Technology Group Holding Ltd (CRDO), reported the sale of ordinary shares.
- The transactions occurred on October 8, 2025.
- Sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Fleming on June 19, 2025.
- A total of 112,580 ordinary shares were disposed across three separate transactions.
- The shares were sold at weighted average prices of $137.8361, $138.6003, and $139.4195.
- Following these transactions, Mr. Fleming directly beneficially owns 458,678 ordinary shares.
Sentiment
Score: 5
Explanation: The sale of shares by a key executive, while reducing insider ownership, was conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests planned liquidity or diversification rather than a reaction to adverse company-specific news. This typically results in a neutral to slightly negative market sentiment.
Positives
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating planned diversification or liquidity rather than a reaction to immediate negative company news.
Negatives
- Chief Financial Officer Daniel W. Fleming reduced his direct beneficial ownership by 112,580 ordinary shares, which decreases insider alignment with shareholders.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The direct beneficial ownership of ordinary shares by the Chief Financial Officer has decreased, which may be viewed as a reduction in insider alignment, though mitigated by the pre-planned nature of the sales.
Key Dates
| Date | Description |
|---|---|
| 06/19/2025 | Rule 10b5-1 trading plan adopted by Daniel W. Fleming. |
| 10/08/2025 | Date of share disposition transactions. |
| 10/10/2025 | Date the Form 4 was signed and filed. |
Recommendation
holdThe reported transactions are routine insider sales executed under a pre-arranged Rule 10b5-1 trading plan, which typically does not signal a change in the company's fundamental outlook. Investors should consider these sales as part of a planned diversification or liquidity strategy rather than a bearish signal, thus warranting a 'Hold' recommendation based solely on this filing.
Keywords
Credo Technology Group, CRDO, insider trading, Form 4, share sale, CFO, Daniel W. Fleming, 10b5-1 plan, equity transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.